BiotechTube
Home/NanoMedSyn/Alain Morère
AM

Alain Morère

Co-founder, Scientific Advisor

NanoMedSyn

Therapeutic Areas

Metabolic DisordersOncologyImmunologyInflammation

NanoMedSyn Pipeline

DrugIndicationPhase
AMFA-Enzyme Conjugate (Pompe Disease)Pompe Disease (Lysosomal Storage Disorder)Pre-clinical

Leadership Team at NanoMedSyn

MG
Marcel Garcia
CEO
JD
Jean-Olivier Durand
Co-founder, Scientific Advisor
MG
Magali Gary-Bobo
Co-founder, Scientific Advisor
View full NanoMedSyn profile